ChiCTR2300070420 版本V1.1 版本创建时间2023/05/28 20:44:46 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300070420 

最近更新日期:

Date of Last Refreshed on:

2023-04-11 17:01:41 

注册时间:

Date of Registration:

2023-04-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于真实世界数据的口腔种植早期失败和并发症的预后预测模型研究

Public title:

A prognostic model for predicting early failure and complications of oral implants based on real-world data

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于真实世界数据的口腔种植早期失败和并发症的预后预测模型研究

Scientific title:

A prognostic model for predicting early failure and complications of oral implants based on real-world data

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张金琳 

研究负责人:

陈博 

Applicant:

JinLinZhang 

Study leader:

BoChen 

申请注册联系人电话:

Applicant telephone:

+86 22 23332070

研究负责人电话:

Study leader's
telephone:

+86 22 23332070

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zjinlin819@163.com

研究负责人电子邮件:

Study leader's E-mail:

chenbo@tmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

天津市和平区气象台路12号天津医科大学口腔医院

研究负责人通讯地址:

天津市和平区气象台路12号天津医科大学口腔医院

Applicant address:

Stomatological Hospital Of Tianjin Medical University, No.12, Meteorological Terrace Road, Heping District, Tianjin

Study leader's address:

Stomatological Hospital Of Tianjin Medical University, No.12, Meteorological Terrace Road, Heping District, Tianjin

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津医科大学口腔医院

Applicant's institution:

Stomatological Hospital Of Tianjin Medical University

研究负责人所在单位:

天津医科大学口腔医院

Affiliation of the Leader:

Stomatological Hospital Of Tianjin Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

TMUhMEC20230205

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

天津医科大学口腔医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Stomatological Hospital Of Tianjin Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-14 00:00:00

伦理委员会联系人:

黄昕

Contact Name of the ethic committee:

Xin Huang

伦理委员会联系地址:

天津市和平区气象台路12号天津医科大学口腔医院

Contact Address of the ethic committee:

Stomatological Hospital Of Tianjin Medical University, No.12, Meteorological Terrace Road, Heping District, Tianjin

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

天津医科大学口腔医院

Primary sponsor:

Stomatological Hospital Of Tianjin Medical University

研究实施负责(组长)单位地址:

天津市和平区气象台路12号

Primary sponsor's address:

No.12, Meteorological Terrace Road, Heping District, Tianjin

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

天津

市(区县):

Country:

China

Province:

TianJin

City:

单位(医院):

天津医科大学口腔医院

具体地址:

天津市和平区气象台路12号

Institution
hospital:

Stomatological Hospital Of Tianjin Medical University

Address:

No.12, Meteorological Terrace Road, Heping District, Tianjin

经费或物资来源:

自筹

Source(s) of funding:

Self-financing

研究疾病:

口腔种植早期失败和术后并发症  

Target disease:

Early failure and postoperative complications of oral implants

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

(1)通过回顾性研究探究口腔种植早期失败和并发症的影响因素,以降低其发生率。 (2)根据研究结果,构建口腔种植早期失败及并发症的预测模型,为临床决策提供早期预警机制。  

Objectives of Study:

(1) To investigate the influencing factors of early failure and complications of oral implants through a retrospective study in order to reduce their incidence. (2) To construct a prediction model for early failure and complications of oral implants based on the study results to provide an early warning mechanism for clinical decision-making.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①天津医科大学口腔医院种植科具有10年以上种植经验的主任医生2017年1月至2022年7月植入的种植体
②符合种植修复适应症
③无明显种植手术禁忌症
④患者知情同意

Inclusion criteria

① Implants placed from January 2017 to July 2022 by a chief physician with more than 10 years of implant experience in the Department of Implantology of Tianjin Medical University Dental Hospital
② Meet the indications for implant restoration
③ No obvious contraindications to implant surgery
④ Patient informed consent

排除标准:

①正在接受放疗或化疗的患者
②并发骨质疏松、癌症、甲肝、丙肝、甲状腺功能异常、高血脂、抑郁症、克罗恩病、服用双磷酸盐的患者
③临床资料不完整的患者

Exclusion criteria:

① Patients who are receiving radiotherapy or chemotherapy
② Patients with coexisting osteoporosis, cancer, hepatitis A, hepatitis C, abnormal thyroid function, hyperlipidemia, depression, Crohn's disease, or taking bisphosphonates
③ Patients with incomplete clinical information

研究实施时间:

Study execute time:

From 2023-04-12 00:00:00 To 2023-05-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-04-12 00:00:00 To 2023-05-01 00:00:00

干预措施:

Interventions:

组别:

种植

样本量:

674

Group:

implant

Sample size:

干预措施:

对牙列缺损进行种植体植入

干预措施代码:

Intervention:

Implant placement for dental defects

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

天津 

市(区县):

 

Country:

china

Province:

TianJin

City:

单位(医院):

天津医科大学口腔医院 

单位级别:

三级甲等专科医院 

Institution
hospital:

Stomatological Hospital Of Tianjin Medical University

Level of the institution:

Grade 3 A Specialty Hospital

测量指标:

Outcomes:

指标中文名:

早期失败

指标类型:

主要指标

Outcome:

Early Failure

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后并发症

指标类型:

主要指标

Outcome:

Postoperative complications

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 17 years
最大 Max age 82 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

不涉及随机

Randomization Procedure (please state who generates the random number sequence and by what method):

No randomness involved

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

如果对原始数据感兴趣,可联系通讯作者获取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

If you are interested in the original data, please contact the corresponding author

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

资料收集后,对资料进行编号,录入Excel数据库

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

After the data is collected, the data is numbered and entered into an Excel database

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2023-04-11 17:01:12